
Zynerba Pharmaceuticals ZYNE
Quarterly report 2023-Q2
added 08-14-2023
Zynerba Pharmaceuticals EBITDA per Share 2011-2026 | ZYNE
Annual EBITDA per Share Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.82 | -0.93 | -1.92 | -1.55 | -2.63 | -2.53 | -2.55 | -2.81 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.82 | -2.81 | -1.97 |
Quarterly EBITDA per Share Zynerba Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.22 | - | -0.19 | -0.22 | -0.22 | - | -0.25 | -0.24 | -0.2 | -0.35 | -0.31 | -0.83 | -0.46 | -0.49 | -0.08 | -0.52 | -0.49 | -0.46 | -0.48 | -0.88 | -0.92 | -0.61 | -0.65 | -0.64 | -0.64 | -0.69 | -0.67 | -0.71 | -0.48 | -0.62 | -0.66 | -1.12 | -1.03 | -0.96 | -2.63 | -2.27 | -0.49 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.08 | -2.63 | -0.648 |
EBITDA per Share of other stocks in the Drug manufacturers industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
-0.32 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | ||
|
Assertio Holdings
ASRT
|
1.32 | $ 19.13 | -0.42 % | $ 122 M | ||
|
Bausch Health Companies
BHC
|
6.1 | $ 5.35 | - | $ 1.95 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | - | - | $ 2.06 B | ||
|
Canopy Growth Corporation
CGC
|
-0.89 | $ 1.02 | 2.0 % | $ 110 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
0.22 | $ 3.2 | 1.03 % | $ 45 M | ||
|
Cronos Group
CRON
|
-0.504 | $ 2.57 | 1.58 % | $ 1.33 B | ||
|
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | ||
|
Emergent BioSolutions
EBS
|
-11.7 | $ 8.19 | -0.49 % | $ 419 M | ||
|
Evolus
EOLS
|
-0.39 | $ 4.08 | 1.24 % | $ 263 M | ||
|
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | ||
|
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | ||
|
DURECT Corporation
DRRX
|
-1.4 | - | - | $ 50.1 M | ||
|
Harrow Health
HROW
|
0.87 | $ 35.64 | 0.92 % | $ 1.31 B | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-10.3 | - | -0.1 % | $ 2.03 B | ||
|
Evoke Pharma
EVOK
|
-2.22 | - | - | $ 36.6 M | ||
|
HEXO Corp.
HEXO
|
-0.67 | - | 2.45 % | $ 38.1 M | ||
|
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M | ||
|
Aurora Cannabis
ACB
|
-1.67 | $ 3.49 | 1.45 % | $ 86.3 M | ||
|
OrganiGram Holdings
OGI
|
-0.36 | $ 1.4 | 1.44 % | $ 402 M | ||
|
Organogenesis Holdings
ORGO
|
0.09 | $ 2.28 | 1.79 % | $ 300 M | ||
|
Pacira BioSciences
PCRX
|
0.12 | $ 22.78 | 0.35 % | $ 1.05 B | ||
|
Relmada Therapeutics
RLMD
|
-1.5 | $ 6.92 | -1.0 % | $ 273 M | ||
|
Rockwell Medical
RMTI
|
-0.07 | $ 0.91 | -4.84 % | $ 32.7 M | ||
|
SCYNEXIS
SCYX
|
-0.32 | $ 0.88 | -0.35 % | $ 43.9 M | ||
|
Solid Biosciences
SLDB
|
-2.03 | $ 7.56 | 0.93 % | $ 662 M | ||
|
Sundial Growers
SNDL
|
-71 | $ 1.38 | 1.1 % | $ 3.37 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 2.36 | -0.42 % | $ 2.93 M | ||
|
Tilray
TLRY
|
-2.22 | $ 6.71 | 2.37 % | $ 4.15 B | ||
|
Veru
VERU
|
-0.27 | $ 2.34 | 2.18 % | $ 316 M | ||
|
Viatris
VTRS
|
2.92 | $ 13.35 | -0.71 % | $ 16 B | ||
|
Jupiter Wellness
JUPW
|
0.16 | - | - | $ 33.6 M | ||
|
cbdMD
YCBD
|
-0.66 | $ 0.73 | - | $ 3.15 M | ||
|
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | ||
|
Neoleukin Therapeutics
NLTX
|
-4.7 | - | - | $ 193 M | ||
|
OptiNose
OPTN
|
-0.2 | - | - | $ 1.08 B | ||
|
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | ||
|
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | ||
|
ProPhase Labs
PRPH
|
1.79 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
-1.13 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | ||
|
Zomedica Corp.
ZOM
|
-0.08 | - | -0.21 % | $ 98 M | ||
|
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | ||
|
China Pharma Holdings
CPHI
|
-0.4 | $ 0.63 | - | $ 2.7 M | ||
|
TherapeuticsMD
TXMD
|
-0.35 | $ 2.01 | 0.5 % | $ 23.3 M |